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Background: Receptor for advanced glycated end product (RAGE) expression is a prominent feature of atherosclerosis.
We have previously shown in apoE null mice uptake of a radiolabeled anti-RAGE antibody in atherosclerotic plaque
and now evaluate RAGE-directed imaging to identify advanced plaques in a large animal model.
Methods: Nine hyperlipidemic (HL) pigs were injected with 603.1 ± 129.5 MBq of 99mTc-anti-RAGE F(ab′)2, and after
6 h (blood pool clearance), they underwent single-photon emission computed tomography/computed tomography
(SPECT/CT) imaging of the neck, thorax, and hind limbs. Two HL pigs received 99mTc non-immune IgG F(ab′)2, and three
farm pigs were injected with 99mTc-anti-RAGE F(ab′)2. After imaging, the pigs were euthanized. The aorta from the root
to bifurcation was dissected, and the innominates, proximal carotids, and coronaries were dissected and counted,
stained for H&E and RAGE, and AHA-classified.
Results: On pathology, 24% of the arterial segments showed AHA class III or IV lesions, and these lesions were
confined almost exclusively to coronaries and carotids with % stenosis from 15% to 65%. Scatter plots of %ID/g for
class III/IV vs. I/II lesions showed almost complete separation. Focal vascular uptake of tracer visualized on SPECT scans
corresponded to class III/IV lesions in the coronary and carotid vessels. In addition, uptake in the hind limbs was noted
in the HL pigs and corresponded to RAGE staining of small arteries in the muscle sections. Correlations for the vascular
lesions were r = 0.747, P = 0.001 for %ID vs. %ID/g and r = 0.83, P = 0.002 for %ID/g vs. % RAGE staining.
Conclusions: Uptake of radiolabeled anti-RAGE antibody in coronary and carotid fibroatheroma and in the small
arteries of the hind limbs in a relevant large animal model of atherosclerosis supports the important role of RAGE in
atherosclerosis and peripheral artery disease as a target for imaging and treatment.
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Receptor for advanced glycation end products (RAGE) is
a multi-ligand receptor that plays an important role in
the initiation and progression of atherosclerotic plaque
and in mediating vascular inflammation in a variety of
conditions [1,2]. It is constitutively expressed in low
levels on smooth muscle cells and endothelial cells in
vascular endothelium, and the expression of RAGE
increases in the vascular wall in response to a number of
stimuli including hyperlipidemia and hyperglycemia [3].* Correspondence: lj2129@cumc.columbia.edu
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in any medium, provided the original work is pStudies investigating RAGE expression in mouse
models of atherosclerosis have used tissue extracts for
protein analysis and quantitative immunohistochemistry
[4,5]. While these molecular biology tools are standard,
they are limited in showing the extent and distribution
of RAGE expression in the entire animal and require
post-mortem tissue for analysis. Molecular imaging can
show the distribution and intensity of the probe signal
over the entire animal to identify the location and extent
as well as the semi-quantitative expression of the target
in an intact animal. This imaging approach is well suited
to describe the expression of a receptor such as RAGE
in atherosclerosis, a disease involving the entire arterial
vascular tree.an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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ment targeting a unique peptide sequence on the extracel-
lular domain of the RAGE receptor and have shown in
mouse models of atherosclerosis (apoE null) uptake on
in vivo nuclear scans located in the sites of the atheroma in
the aortic root and proximal aorta [6,7]. In developing a
new radiotracer for possible clinical use, it is necessary to
show the results of in vivo imaging in a large animal model.
Swine are commonly used in cardiovascular research due
to similarities in the coronary anatomy and cardiac
function to that of humans. Hyperlipidemic pigs bred in
the domestic swine background have become a useful large
animal model of atherosclerosis [8]. The purpose of this
study was to perform RAGE-directed SPECT imaging to
test the hypothesis that the signal from the uptake of
the radiolabeled probe in atheroma can be detected
in a large animal model of atherosclerosis comparable
to humans and to investigate the extent and distribu-
tion of RAGE expression in the arterial vascular tree
and localize to atheroma.
Methods
Animals
This study was designed as a single group of hyperlipidemic
(HL) pigs for two purposes: to evaluate the extent and
severity of atherosclerosis and RAGE expression in this
large animal model and to see whether the signal from a
radiolabeled antibody coming from this receptor can be
visualized on in vivo imaging and correlated with quantita-
tive histomorphometry. Four farm pigs were used as disease
control. Specificity was determined in two HL pigs injected
with isotype control antibody. All animal experiments were
performed with the approval of the Institutional Animal
Care and Use Committee of Columbia University. Nine
juvenile male LDL-deficient (Rapacz) swine were sent to us
from the University of Wisconsin-Madison. Seven arrived
at age 3 months and were maintained in house for
approximately 9 months or to 1 year of age, and two
HL pigs arrived at age 11 months and were maintained in
house for 1 month. Four age- and weight-matched farm
pigs were also studied for blood pool clearance and as
disease controls for imaging and ex vivo well counting.
All pigs received a high-fat swine diet (15% lard, 1.2%
cholesterol) (Harlan Teklad, Madison, WI, USA). Weights
were obtained monthly, and on the same day, the animals
were sedated for venous blood samples for fasting glucose,
blood chemistry profile, and lipid profile.
Anti-RAGE antibody
The anti-RAGE antibody is a murine monoclonal antibody
against the V-domain of RAGE designed to display immu-
noreactivity in mice, pigs, and human. The peptide
sequence and production of the murine hybridoma has
been described [6]. The monoclonal anti-RAGE antibodywas fragmented using pepsin digestion into F(ab′)2 frag-
ments (approximately 110 kDa) and immunoreactivity
tested by ELISA using soluble RAGE antigen. Direct
coupling of diethylenetriaminepentaacetic acid (DTPA)
(bicyclic anhydride) to anti-RAGE F(ab′)2 antibody
fragments for 99mTc labeling was performed as previ-
ously described [6,7]. The mean specific activity was
8.14 ± 3.8 MBq per microgram of protein, and the
mean radiopurity was 98% ± 0.83% by instant thin-layer
chromatography.
Blood pool clearance
Ear vein catheters were placed in both ears of four
farm pigs. Into one ear vein, an average dose of
16 mCi of 99mTc-anti-RAGE F(ab′)2 was injected, and
from the opposite ear vein, 1-ml samples were withdrawn
at 2, 5, 10, 15, 20, 30, 45, 60, 90, 120, 180, 240, 300, and
360 min. From each tube, 50 μl was pipetted into pre-
weighed tubes and counted in a gamma well counter. The
counts vs. time were averaged for each time point and
plotted. These pigs were also used for in vivo imaging and
ex vivo well counting and histology.
Radiotracer injection and imaging
At approximately 1 year of age, each HL pig was sedated,
and angiocatheters were placed in both ear veins. A dose
of 16.3 ± 3.5 mCi (0.3 ± 0.1 mCi/kg, 658.6 ± 148.0 MBq,
63.6 ± 13.3 MBq/kg) of 99mTc-anti-RAGE F(ab′)2 antibody
in 5-ml saline with a flush was injected through an ear
vein. Two of these nine HL pigs also received 99mTc non-
immune IgG(Fab′)2 as well as
99mTc-anti-RAGE F(ab′)2,
1-week apart with SPECT imaging following both
injections, but the tissue was obtained after the control
antibody. Four weight-matched farm pigs received injection
of 99mTc-anti-RAGE (17.5 mCi, 0.4 mCi/kg, 653.7 MBq,
12.9 MBq/kg) and were imaged.
Imaging
After injection, the pigs were awakened and returned to
their cages for 5-6 h to allow for blood pool clearance, then
were re-sedated, intubated, and transported to the imaging
laboratory where they first underwent CT angiography
followed by SPECT/CT imaging (Philips Precedence 16
slice Hybrid SPECT/CT, Philips Healthcare, Andover, MA,
USA). Each pig was injected with 100-ml non-ionic
iodinated contrast agent Optiray 320 (Covidien, Mansfield,
MA, USA) through the ear vein following test bolus.
Scouts comprised neck to abdomen/pelvis. The following
acquisition protocol was used: 120 kV, tube current
337 mA, collimation 16 × 0.75 mm, pitch 0.688, and slice
thickness 0.8 mm. Acquisition trigger was set for 180 HU
at aortic arch. Following CT angiogram, hybrid SPECT/CT
imaging was performed with bed positions to include the
chest, neck, and hind limbs. Each SPECT scan was
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360°. At completion of the imaging, the pigs were returned
to the necropsy suite of the Institute of Comparative
Medicine and euthanized with a bolus of Euthasol (100 to
120 mg/kg IV; Virbac Animal Health, St. Louis MO, USA).
Scan analysis
The SPECT scans were reconstructed using filtered back
projection, and the CT and SPECT images blended using
Syntegra software (Philips, Andover, MA, USA). Focal
regions of tracer uptake were localized to the territory of
the carotids on sagittal and coronal blended SPECT/CT
scans, and regions of interest were drawn around the
uptake on the coronal slices to comprise the area of
focal uptake excluding the most cephalad and caudad
slices to reduce partial volume effect, and the counts
from these regions were summed and converted to %ID
using measured camera efficiency values and decay
times. Because of the very low myocardial uptake, focal
hotspots in coronary artery territories were visualized
and localized on the blended chest CTA/SPECT images
(Syntegra). For the hind limbs, the ROIs were drawn
around sequential 1-voxel thick transverse slices using
the blended SPECT/CT to define limb boundaries
from the proximal femur to the distal tibia/fibula,
and the activity from all the slices were summed for
each limb.
Necropsy and tissue preparation
The chest and abdomen were opened, the blood was
drained from the vasculature, the heart was removed,
and the coronaries from the opening of the coronary
sinus to distal vessel were dissected out and rinsed with
PBS. The aorta was dissected and removed from the












Figure 1 Blood pool clearance of 99mTc-anti-RAGE F(ab′)2 in a farm piproximal femoral arteries and the major arch vessels
(the brachiocephalic trunk (innominate artery) and
carotid arteries). The tissue was cleaned and rinsed
carefully and placed in a plastic tray kept moist in 10%
formalin solution and placed on one of the detectors used
for the in vivo scanning and imaged for 20 min. After
imaging, representative cross-sections of the arteries were
cut and labeled for well counting and sectioning. Each
coronary was cut in four segments. The aorta was sampled
as full-width cross-sectional segments from the aortic root
through the abdominal aorta for a total of 12 segments
per animal. The samples were taken from the proximal,
mid, and distal innominate, from the proximal and mid
right and left carotids, and from the proximal and mid
femoral arteries. In addition, three samples were taken
from each gastrocnemius muscle (six samples per pig).
Each sample was weighed and counted in the gamma well
counter (Wallac Wizard 1470, PerkinElmer, Waltham,
MA, USA) along with an aliquot of the injected dose
as standard and the %ID/g calculated for each sample
and subsequently embedded in paraffin for section-
ing. In selected animals, the lungs, liver, and heart
were removed, weighed, and counted in the gamma
well counter and then embedded in paraffin for
sectioning.
Immunohistology
For immunohistochemical analyses, serial sections were
deparaffinized in xylene, treated with 0.3% hydrogen
peroxide for 20 min, and incubated in protein-free
block (Dako Inc., Carpinteria, CA, USA) for 10 min to
inhibit the non-specific binding of primary antibody. All
sections were stained with hematoxylin and eosin (H&E).
Staining for RAGE was performed using monoclonal
anti-RAGE antibody (50 μg/ml). Macrophages were200 250 300 350 400
minutes
g.








Proximal LCx coronary artery 
Figure 2 Vascular pathology. The top set of panels shows, from left to right, a cross-section of an H&E-stained carotid artery at ×4 magnification
showing a thick cap fibroatheroma of proximal carotid artery and selected regions of the lesion in ×10 and ×40 with staining for RAGE, macrophages
(Mac), and smooth muscle cells (SMCs). The lower panels show, on the left, the H&E sections from a proximal left circumflex lesion (LCx) (same lesion
shown in Figure 3) and selected regions stained for RAGE, macrophages, and smooth muscle cells. The secondary antibody with HRP stained the target
cells a reddish brown color.
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San Diego, CA, USA). Smooth muscle cells were identified
using monoclonal mouse anti-human smooth muscle
actin (1:50; Dako Inc.). Secondary staining was per-
formed with HRP-conjugated respective secondary
antibody, followed by diaminobenzidine (DAB substrate
kit for peroxidase; Vector Laboratories, Burlingame,
CA, USA), and counterstaining with Gill's hematoxylin
solution.
Morphometric and immunohistochemical analyses of
the arterial segments were performed using a Nikon
microscope (Tokyo, Japan) and Image-Pro Plus software
(Media Cybernetics Inc., Silver Spring, MD, USA). The
lesion was measured as percent lesion area per total area
of the aorta. RAGE staining was quantified as percent
RAGE staining in the lesion area per total area of the
aorta. Lesion morphology was classified according to theAmerican Heart Association (AHA) criterion from class
I to class IV [9].
Statistical analysis
All data are presented as mean ± standard deviation.
Correlation was assessed using the Pearson product–
moment correlation.
Results
Weights and blood tests
For the nine HL pigs, the average arrival weight was
26.1 ± 4.8 kg, and the final weight was 63.6 ± 12.3 kg.
The average cholesterol levels at arrival and sacrifice were,
respectively, 460.4 ± 93.1 mg/dL and 445.6 ± 72.4 mg/dL,
triglyceride levels 54.1 ± 15.3 mg/dL and 47.1 ± 12.1 mg/dL,
and fasting blood glucose 71.0 ± 9.3 mg/dL and 88.4 ±
20.9 mg/dL. The weight of the farm pigs at time of imaging
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within normal limits for species.
Blood pool clearance and biodistribution
The t1/2 for the first component was 13 min, and for the
second component, it was 220 min (Figure 1). The
lungs, heart, and liver were removed and weighed, and
representative tissue samples were taken and counted in
the well counter to determine the %ID/g of tissue. The
lung activity was high without difference between the
farm pigs and HL pigs representing high constitutive
expression of RAGE in the lungs of domestic swine.
Myocardial expression was low (averaging 0.03% of
the ID). The liver uptake averaged at 16% ID.
Location and extent of atherosclerotic lesions on
histopathology
For the 324 arterial segments sampled on the nine HL
pigs, 283 were good tissue sections. On histology of
these sections, 35 showed AHA class III or IV lesions
(12%), 34 class II lesions (12%), and the remainder class
I or no disease. Occlusive lesions were non-calcified
fibroatheromas (Figure 2). The aortic root, arch, and
thoracic aorta all showed AHA class I and II disease
with only several class III lesions in the thoracic aorta.





Figure 3 SPECT/CT images. The left image is a transverse blended image
the origin of the LCx. The middle and right images show the sagittal and c
uptake that localizes to the left carotid artery, respectively. Both areas of fo
and IV AHA lesions on histology.observed in nine coronaries, ten carotids, and six femoral
arteries. The mean percentage stenosis for the coronaries
was 39% ± 13% (range from 28% to 65%), for the carotids
42% ± 15% (range from 15% to 57%), and for the femoral
arteries 36% ± 11% (range from 20 to 51).
Uptake of 99mTc-anti-RAGE F(ab′)2 in carotid and coronary
arteries
Focal uptake of tracer was noted in regions corresponding
to nine coronary arteries and ten carotid vessels. The
calculated %ID for the coronaries was 1.2 ± 0.4, and for
the carotids 0.7 ± 0.3. All of these vessels, when excised
and sectioned, showed AHA class III and IV atheroscler-
otic lesions. Examples of scans showing focal uptake in
the proximal left circumflex (LCx) and left (L) carotid are
shown in Figure 3.
Planar images of the aorta imaged on the detector are
shown in Figure 4. The farm pigs injected with
99mTc-anti-RAGE F(ab′)2 and HL pigs injected with
99mTc-labeled control antibody did not show appreciable
focal tracer uptake. The HL pigs showed areas of uptake
localized to the distal arch and thoracic aorta correspond-
ing to AHA II lesions on histology. The %ID calculated
for segments of the excised aorta counted on the detector
of the gamma camera for the proximal, mid, and distal





at the level of the aortic root showing focal uptake corresponding to
oronal blended images at the level of the anterior neck showing focal
cal uptake corresponded to higher values for %ID/g from well counter
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anti-RAGE
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Figure 4 Ex vivo imaging of the aorta. The top-row images are the planar scans of the aortas from a HL pig injected with 99mTc-anti-RAGE F
(ab′)2 (left), farm pig injected with the same antibody in the middle, and a HL pig injected with radiolabeled control antibody on the right. Tracer
uptake is seen in the distal arch and proximal thoracic aorta in the HL pig, but no appreciable focal uptake is seen on the aortas from the farm
pig and the HL pig injected with control antibody. The graph below shows uptake as %ID, with blue bar representing the mean ± SD for all the
HL pigs injected with 99mTc-anti-RAGE F(ab′)2 and average values for three farm pigs and two HL injected with non-immune IgG. The small increment
of uptake of 99mTc-anti-RAGE F(ab′)2 over the controls corresponded with low expression on histology.
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experiments were between 4% and 5% (Figure 4).
Gamma well counting of vascular tissue
The 36 arterial sections from each pig were counted in
the gamma well counter, and counts as %ID/g were
calculated for all samples for the nine HL pigs, the
four farm pigs, and the two HL pigs injected with
non-immune IgG F(ab′)2. The average ± SD for vascular
tissue sections with highest values for %ID/g for each
vascular segment for the nine pigs are shown in Figure 5A.
The distribution of probe uptake corresponded to the
distribution of atherosclerotic lesions with lowest uptake in
the aortic root and arch, and the highest values for
the coronary arteries and carotids.To better assess the relationship between tracer
uptake and AHA class, all histological sections from the
innominate, left and right carotid, LAD, RCA, LCx, aortic
root, arch, and thoracic aorta for each animal were
grouped into class I and II lesions (minimal disease) and
class III and IV lesions (more advanced). The tracer
uptake as %ID/g from well counting for these sections were
plotted as scattergrams (Figure 5B). There was minimal
overlap of values for the two groups. Only two vessels with
minimal disease had an uptake of >3.5% ID/g × 10−4, and
only one with advanced disease had an uptake of <3.5
(Figure 5B). The uptake in all class III and IV lesions
in the coronary and carotid vessels was visible on the
SPECT scans, and none of these vessels with only
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Figure 5 Quantitative tissue uptake of radiotracer. (A) Bar graph of distribution of uptake as %ID/g from the gamma well counting of
vascular tissue from the HL pigs (blue bars) (mean ± SD) and averages of the controls. Innom, innominate artery; abd, abdominal; LFA, left femoral
artery; RFA, right femoral artery. (B, C) Correlations between %ID from scan and % RAGE staining with %ID/g.
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of 99mTc-anti-RAGE F(ab′)2 were plotted vs. values
for %ID/g for the same vascular segments counted on the
gamma well counter. There was a significant correlation:
r = 0.747, P < 0.001 (Figure 5C).
Quantitative staining of atheroma for RAGE
Quantitative immunostaining for RAGE as % vessel area
ranged from 5% to 20% and localized to media and
neointima. Serial sections stained for endothelial cells,
macrophages, and smooth muscle cells showed predomin-
ant co-localization of RAGE staining with smooth muscle
cells and macrophages (Figure 2). When % RAGE staining
was plotted vs. vascular uptake of 99mTc-anti-RAGE F(ab′)2,
there was a significant correlation: r = 0.824, P < 0.001.
Hind-limb uptake of anti-RAGE antibody
All nine HL pigs showed non-obstructive fibroatheromas
at the bifurcation of the distal aorta into the ileofemoral
branches seen on histology (Figure 6), but visualizing
focal uptake of the radiolabeled probe in these lesions
was difficult due to the proximity to the bladder and
bowel. In distinction to focal uptake seen in atheroma in
large vessels, a pattern of diffuse tracer uptake was
observed in the hind limbs of all the HL pigs. Uptake
as %ID calculated as the sum of sequential 1-voxel-thick
transverse slices from proximal femur to distal tibia/fibula
for the nine HL pigs was 6.73 ± 0.80, and for the farm pigs,
the average value was 3.75. The blended SPECT/CT
coronal and sagittal images from one farm pig and oneHL pig are shown in Figure 6. The gastrocnemius muscle
immunohistology showed positive RAGE staining in
the endothelial layer of small arteries on the biopsy
specimens, and therefore, the diffuse pattern of tracer
uptake on the scans is interpreted as RAGE expression in
small arterial walls.
Discussion
This paper is the first to report the potential value of
imaging RAGE expression in atheroma throughout the
vascular tree in a large animal model genetically altered
to develop advanced atherosclerotic lesions similar in
morphology to human disease [8,10-13]. Using SPECT
imaging, the focal uptake of a 99mTc-labeled probe bind-
ing RAGE was seen in the distribution of AHA class III
and IV lesions in the carotid and coronary arteries. No
focal uptake was seen in regions corresponding to class I
and II lesions. These findings were confirmed by ex vivo
well counting of the vascular tissue. In addition, diffuse
uptake of RAGE targeting probe was seen in the lower
extremities and histopathology showed increase RAGE
expression in small- and medium-size arteries.
RAGE is a multi-ligand receptor that binds non-
enzymatically glycosylated proteins or AGEs and
other ligands initiating downstream pathways import-
ant in atherogenesis [14-18]. Knocking out RAGE in
atherosclerotic-prone mice reduces the development
of atherosclerosis [19,20], further supporting the im-
portance of RAGE-initiated pathways in atherogenesis
and plaque progression. Pathological studies of human






Figure 6 Hind limb imaging and histology. Top 4 images are coronal (left) and sagittal (right) slices from SPECT/CT scans of hind limbs of farm
pig (above) and HL pig (below) injected with 99mTc anti-RAGE F(ab′)2. There is diffuse tracer uptake in both hind limbs of the HL pig compared to
low uptake in the farm pig. Bottom images on the left are the CTA showing atheroma at the iliac bifurcation in a HL pig and on the right the
H&E-stained cross-sections from the femoral artery of a HL pig showing fibrous atheroma and from the gastrocnemius muscle of a HL pig
showing RAGE staining in the small arterial walls.
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importance of RAGE in atherosclerosis and peripheral
artery disease. To localize and quantify RAGE expres-
sion, Burke et al. found RAGE expression in fibroathero-
mas from subjects with sudden cardiac death [21], and
Cipollone et al. found RAGE expression in carotid plaque
from patients with transient ischemic events [22]. A path-
ology study reported by Ritthaler et al. in 1995 documented
prominent enhancement of endothelial RAGE expression
in small-and medium-size arteries in the lower extremities
of patients with occlusive peripheral vascular disease [23].The development of both SPECT and PET probes
targeting atherosclerosis towards the goal of finding a
non-invasive screening test for subjects at highest risk
for CV events (both myocardial infarction and stroke) has
been a major focus for investigators in CV molecular
imaging. As progress in molecular biology has identified
an increasing number of potential sites for binding
ligands, a large number of probes using nuclear, optical,
ultrasound, and MR reporters have been developed for
preclinical small animal studies [24]. Nuclear probes offer
the advantage of small-size molecules that can gain access
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larger probes that are confined to binding sites expressed
on the vascular lining. The spatial resolution for the newer
SPECT detectors even at the depth of the heart is at least
twice the diameter of a coronary artery and PET resolution
is at the border of the coronary diameter size. Despite
limited resolution, focal uptake of tracers can be seen in
small structures on in vivo scans as ‘beacons.’ The strength
of the signal and ability to see it depend on the number of
binding sites for the probe as well as attenuation and
scatter from adjacent activity. Correlation with quantitative
immunohistology allows us to identify a threshold level of
target expression to permit in vivo imaging. The very fact
that one can see this target indicates a high level of
biological expression which would have clinical significance.
Hybrid imaging (SPECT/CT or PET/CT) when com-
bined with angiography can optimize localization of
focal tracer uptake to a vascular structure. Vascular
uptake of 18 F-FDG tracks metabolic activity of plaque
macrophages and therefore plaque inflammation, a
pathological feature of vulnerability [25]. Because the
myocardium relies on glucose as a substrate for metab-
olism, FDG has limited application for coronary imaging
due to high background [26]. Carotid plaques are an easier
target than coronary plaques due to larger size of vessels,
less motion, and less attenuation. While focal uptake of
FDG seen on PET/CT scans has been reported to correlate
with plaque macrophages, limitations to 18 F-FDG carotid
plaque imaging occur due to residual blood pool activity,
adjacent tissue uptake, and effects of blood glucose levels
on uptake [27]. While RAGE plays a role in a number of
signaling pathways, its role in atherosclerosis is mediated
mostly via inflammation pathways and, in this respect,
similar to FDG. In contrast to FDG, 99mTc anti-RAGE
F(ab′)2 probe has very low myocardial uptake due to
low constitutive RAGE expression in the non-ischemic
myocardium. Based on our experience with RAGE lung
tissue staining in different species including human, the
high lung uptake observed which interfered with im-
aging the aorta, is unique to the pig. The wide availabil-
ity of hybrid imaging platforms as well as software for
accurate registration of SPECT or PET scans with CT
scans now makes it practical to apply hybrid nuclear/
CT atherosclerotic plaque imaging as selective screening
for very high risk patients.
Conclusions
The results of the current study documented in a large
animal model of atherosclerosis with plaque characteristics
similar to those of man that the focal uptake of a radiola-
beled antibody targeting RAGE which plays an im-
portant role in atherogenesis and plaque vulnerability can
be detected on in vivo imaging with a threshold for
detection at AHA III and IV lesion severity. In addition,semi-quantitative uptake of tracer on in-vivo imaging
localized to distribution of diseased coronary and
carotid vessels correlated with gamma counting of the
tissue and with quantitative staining for RAGE. Diffuse
uptake of the radiolabeled tracer was seen in the hind
limbs corresponding to RAGE expression in the small
arteries. Because RAGE is a multi-ligand receptor and
transduces many important signaling pathways in vascular
disease and atherogenesis, it represents a potentially good
target for imaging atherosclerosis and PAD.
Limitations
The hybrid imaging would have been strengthened if we
were able to perform coronary CT angiograms with
gating to register with the SPECT images. We were
unable to get the heart rates of the pigs low enough to
permit good quality studies on a 16-slice CT scanner.
While the whole body CTA we used to register with
the SPECT to localize tracer uptake was ungated, the
base of the heart where the origins of coronary arteries
are located (Figure 3) has less cardiac motion than
towards the apex, and any motion would serve only
to further blur the focal hotspot but not reduce our
sensitivity to detect it.
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